Microbial and Antibiotic Sensitivity Pattern of High Vaginal Swab Culture Results in Sekondi-Takoradi Metropolis of the Western Region of Ghana: Retrospective Study
European Journal of Clinical and Biomedical Sciences
Volume 2, Issue 5, October 2016, Pages: 45-50
Received: Sep. 12, 2016; Accepted: Nov. 1, 2016; Published: Nov. 23, 2016
Views 3645      Downloads 131
Verner Ndudiri Orish, Department of Microbiology and Immunology, School of Medicine, University of Health and Allied Sciences, UHAS, Ho, Volta Region, Ghana
Jones Ofori-Amoah, Department of Pharmacology, School of Medicine, University of Health and Allied Sciences, UHAS, Ho, Volta Region, Ghana
Mahama François, Department of Mathematics and Statistics, Ho Polytechnic, Ho, Volta Region, Ghana
Bruku Kwesi Silverius, Department of Quality Assurance, Takoradi Polytechnic, Takoradi, Western Region, Ghana
Ebenezer Kofi Mensah, Public Health Laboratory, Effia-Nkwanta Regional Hospital, Sekondi-Takoradi, Western Region, Ghana
Article Tools
Follow on us
Vaginal discharge in women is sometimes caused by candida or aerobic bacteria organisms like E. coli, staphylococcus aureus, and β- haemolytic streptococcus. Culture and sensitivity testing are done from high vaginal swab (HVS) specimen collected from women who come to the clinic complaining of vaginal discharge. Isolation and antibiotic sensitivity of these organisms are key to the successful treatment of the cause of vaginal discharge. This study tends to evaluate the microbial and antibiotic sensitivity pattern of high vaginal swab culture results in the Sekondi-Takoradi metropolis of the Western region of Ghana. This is a 3-year retrospective study conducted in the Public Health laboratory of Effia-Nkwanta Regional Hospital. Records of HVS culture and sensitivity results for 2010-2012 were retrieved and reviewed. A total of 3783 culture and sensitivity results were reviewed. 1483 yielded no growth of pathogenic organisms. Candida species were the predominant microbial organism, 63.2% (1455/2300). Bacteria identified were mostly the aerobic types (845); with Escherichia coli being predominant, 29.9% (235/845), while Morganella morgani was the least bacteria, 0.2% (2/845). Adult women (20-50) had the most pathogens isolated from them, with 79.9% of candida (1047/1455) and 71.2% of the aerobic bacteria (602/845). The least organism isolated was seen in the elderly and children, with 6.3% (92/1455) of candida, 9.7% (82/845) of aerobic bacteria and 6.9% (101/1455) of candida and 8.04% (68/845) of aerobic bacteria respectively. The cephalosporins showed the best antibiotic sensitivity. Candida spp. and aerobic bacteria were the predominant microbial organisms identified from HVS results in the Sekondi-Takoradi Metropolis. Proper laboratory diagnosis to identify causative organisms is vital for optimal therapeutic outcome.
Vaginal Discharge, High Vaginal Swab, Bacterial Vaginosis, Vulvovaginal Candidiasis
To cite this article
Verner Ndudiri Orish, Jones Ofori-Amoah, Mahama François, Bruku Kwesi Silverius, Ebenezer Kofi Mensah, Microbial and Antibiotic Sensitivity Pattern of High Vaginal Swab Culture Results in Sekondi-Takoradi Metropolis of the Western Region of Ghana: Retrospective Study, European Journal of Clinical and Biomedical Sciences. Vol. 2, No. 5, 2016, pp. 45-50. doi: 10.11648/j.ejcbs.20160205.13
Copyright © 2016 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Mylonas I, Friese, K. Genital discharge in women. MMW Fortschritte der Medizin. 2007 Sept 6; 149 (35-36), 42.
Gingelmaier A, Friese, K. Inflammatory diseases of the vulva and vagina. Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete. 2006 Feb; 57 (2), 155.
Workowski KA, Berman, S. Sexually transmitted diseases treatment guidelines, 2010.
Mayaud P, Mabey D. Approaches to the control of sexually transmitted infections in developing countries: old problems and modern challenges. Sexually transmitted infections. 2004 Jun 1; 80 (3), 174-182.
World Health Organization. Global prevalence and incidence of selected curable sexually transmitted infections: overview and estimates.
Hillier S, Holmes KK. Bacterial vaginosis. In: Holmes KK, Sparling PF, Ma ̊rdh P-A, Lemon SM, Stamm WE, Piot P, Wasserheit JN, eds. Sexually transmitted diseases 3rd ed. New York: McGraw-Hill, 1999
Schwebke, J R., Hillier, SL, Sobel, JD, McGREGOR, JA, Sweet, RL. Validity of the vaginal gram stain for the diagnosis of bacterial vaginosis. Obstetrics & gynecology. 1996 Apr 1; 88 (4, Part 1), 573-576.
Gibbs RS. Infectious diseases of the female genital tract. 2nd ed. Baltimore: Williams and Wilkins, 1990
Puapermpoonsiri S, Kato N, Watanabe K, Ueno K, Chongsomchai C, Lumbiganon P. Vaginal microflora associated with bacterial vaginosis in Japanese and Thai pregnant women. Clinical infectious diseases. 1996 Oct 1; 23 (4): 748-52.
Mikamo H, Sato Y, Hayasaki Y, Hua YX, Tamaya T. Vaginal microflora in healthy women with Gardnerella vaginalis. Journal of Infection and Chemotherapy. 2000 Sep 1; 6 (3): 173-7.
Harms G, Matull R, Randrianasolo D, Andriamiadana J, Rasamindrakotroka A, Kirsch T, Hof U, Rarivoharilala E, Korte R. Pattern of sexually transmitted diseases in a Malagasy population. Sexually transmitted diseases. 1994 Nov 1; 21 (6): 315-20.
Goldenberg RL, Klebanoff MA, Nugent R, Krohn MA, Hillier S, Andrews WW. Bacterial colonization of the vagina during pregnancy in four ethnic groups. American journal of obstetrics and gynecology. 1996 May 31; 174 (5): 1618-21.
Pirotta M, Fethers KA, Bradshaw CS. Bacterial vaginosis: more questions than answers. Australian family physician. 2009 Jun 1; 38 (6): 394. .Myziuk L, Romanowski B, Johnson SC. BVBlue test for diagnosis of bacterial vaginosis. Journal of clinical microbiology. 2003 May 1; 41 (5): 1925-8.
Donders GG, Vereecken A, Bosmans E, Dekeersmaecker A, Salembier G, Spitz B. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG: An International Journal of Obstetrics & Gynaecology. 2002 Jan 1; 109 (1): 34-43.
Mumtaz S, Ahmad M, Aftab I, Akhtar N, ul Hassan M, Hamid A. Aerobic vaginal pathogens and their sensitivity pattern. J Ayub Med Coll Abbottabad. 2008 Jan; 20 (1): 113-7.
Fan A, Yue Y, Geng N, Zhang H, Wang Y, Xue F. Aerobic vaginitis and mixed infections: comparison of clinical and laboratory findings. Archives of gynecology and obstetrics. 2013 Feb 1; 287 (2): 329-35.
Donders GG, Bellen G, Rezeberga D. Aerobic vaginitis in pregnancy. BJOG: An International Journal of Obstetrics & Gynaecology. 2011 Sep 1; 118 (10): 1163-70.
Sobel JD. Vulvovaginal candidosis. The Lancet. 2007 Jun 15; 369 (9577): 1961-71.
Adanu RM, Seffah J, Anarfi JK, Lince N, Blanchard K. Sexual and reproductive health in Accra, Ghana. Ghana medical journal. 2012 Jun 1; 46 (2): 58-65.
Apea-Kubi KA, Yamaguchi S, Sakyi B, Kishimoto T, Ofori-Adjei D, Hagiwara T. Neisseria gonorrhoea, Chlamydia trachomatis, and Treponema pallidum infection in antenatal and gynecological patients at Korle-Bu Teaching Hospital, Ghana. Jpn J Infect Dis. 2004 Dec 1; 57 (6): 253-6.
Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. American journal of clinical pathology. 1966 Apr; 45 (4): 493.
Mancuso AC, Ryan GL. Normal Vulvovaginal Health in Adolescents. Journal of pediatric and adolescent gynecology. 2015 Jun 30; 28 (3): 132-5.
Mitchell H. Vaginal discharge—causes, diagnosis, and treatment. Bmj. 2004 May 27; 328 (7451): 1306-8.
McCathie R. Vaginal discharge: common causes and management. Current Obstetrics & Gynaecology. 2006 Aug 31; 16 (4): 211-7.
Berg AO, Heidrich FE, Fihn SD, Bergman JJ, Wood RW, Stamm WE, Holmes KK. Establishing the cause of genitourinary symptoms in women in a family practice: comparison of clinical examination and comprehensive microbiology. JAMA. 1984 Feb 3; 251 (5): 620-5.
Geiger AM, Foxman B, Gillespie BW. The epidemiology of vulvovaginal candidiasis among university students. American Journal of Public Health. 1995 Aug; 85 (8_Pt_1): 1146-8.
Joishy M, Ashtekar CS, Jain A, Gonsalves R. Do we need to treat vulvovaginitis in prepubertal girls?. BMJ. 2005 Jan 22; 330 (7484): 186-8.
Banerjee K, Curtis E, de San Lazaro C, Graham JC. Low prevalence of genital candidiasis in children. European Journal of Clinical Microbiology and Infectious Diseases. 2004 Sep 1; 23 (9): 696-8.
Farage M, Maibach H. Lifetime changes in the vulva and vagina. Archives of gynecology and obstetrics. 2006 Jan 1; 273 (4): 195-202.
Sobel JD. Vaginitis. New England Journal of Medicine. 1997 Dec 25; 337 (26): 1896-903.
Jacobsen SÁ, Stickler DJ, Mobley HL, Shirtliff ME. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clinical microbiology reviews. 2008 Jan 1; 21 (1): 26-59.
Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Disease-a-Month. 2003 Feb 28; 49 (2): 71-82.
Khan I, Khan UA. A hospital based study of frequency of aerobic pathogens in vaginal infections. J Rawal Med Coll. 2004; 29 (1): 22-5.
Gajer P, Brotman RM, Bai G, Sakamoto J, Schütte UM, Zhong X, Koenig SS, Fu L, Ma ZS, Zhou X, Abdo Z. Temporal dynamics of the human vaginal microbiota. Sci. Transl. Med. 4: 132 ra 152.medicine. 2012 May 2; 4 (132): 132 ra 52-.
Hafiz S, Hafiz AN, Ali L, Chughtai AS, Memon B, Ahmed A, Hussain S, Sarwar G, Mughal T, Awan A, Zaki K. Methicillin resistant Staphylococcus aureus: a multicentre study. J Pak Med Assoc. 2002 Jul; 52 (7): 312-4.
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
Tel: (001)347-983-5186